Richard H. Simon

Active 1976–2024

67
Papers
19,057
Citations
58
h-index
66
i10-index

Citations

Citations per year for Richard H. Simon1978: 3 citations1979: 1 citations1980: 15 citations1981: 6 citations1982: 8 citations1983: 6 citations1984: 20 citations1985: 11 citations1986: 9 citations1987: 16 citations1988: 18 citations1989: 27 citations1990: 25 citations1991: 24 citations1992: 23 citations1993: 24 citations1994: 38 citations1995: 66 citations1996: 62 citations1997: 54 citations1998: 52 citations1999: 65 citations2000: 95 citations2001: 102 citations2002: 197 citations2003: 280 citations2004: 283 citations2005: 297 citations2006: 261 citations2007: 253 citations2008: 249 citations2009: 206 citations2010: 222 citations2011: 222 citations2012: 179 citations2013: 170 citations2014: 133 citations2015: 141 citations2016: 113 citations2017: 110 citations2018: 109 citations2019: 305 citations2020: 305 citations2021: 307 citations2022: 195 citations2023: 130 citations2024: 178 citations2025: 51 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,901 citing papers, 36% of this breakdownUnited Kingdom: 518 citing papers, 6.4% of this breakdownGermany: 483 citing papers, 6% of this breakdownChina: 435 citing papers, 5.4% of this breakdownCanada: 373 citing papers, 4.6% of this breakdownItaly: 331 citing papers, 4.1% of this breakdownFrance: 323 citing papers, 4% of this breakdownSpain: 261 citing papers, 3.2% of this breakdownJapan: 244 citing papers, 3% of this breakdownAustralia: 223 citing papers, 2.8% of this breakdownNetherlands: 188 citing papers, 2.3% of this breakdownSwitzerland: 166 citing papers, 2.1% of this breakdown
0%36%Other 20.1%

Fields

  • Medicine51.9%
  • Biochemistry, Genetics and Molecular Biology34.1%
  • Immunology and Microbiology4.8%
  • Mathematics3.1%
  • Computer Science2.2%
  • Chemistry0.6%
  • Other3.3%

Topics

  • Lymphoma Diagnosis and Treatment6.1%
  • Gene expression and cancer classification4.8%
  • Chronic Lymphocytic Leukemia Research2.9%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis2.4%
  • Bioinformatics and Genomic Networks2.2%
  • Cystic Fibrosis Research Advances1.9%
  • Other79.7%

Coauthors

All papers

Open in search
  1. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas M. Grogan, Thomas P. Miller, M. Leblanc, German Ott, Stein Kvaløy, Jan Delabie, Harald Holte, Peter Krajči, Trond Stokke, Louis M. Staudt - New England Journal of Medicine 2002 cited by 3,859

  2. Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2009 cited by 488

  3. Cystic Fibrosis Foundation Pulmonary Guideline. Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection

    Authors: , , , , , , , , , , , , , , - Annals of the American Thoracic Society 2014 cited by 266

  4. Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emilio Montserrat, Wyndham H. Wilson, Elaine S. Jaffe, Richard H. Simon, Liming Yang, John Powell, Hong Zhao, Neta Goldschmidt, Michael Chiorazzi, Louis M. Staudt - New England Journal of Medicine 2004 cited by 1,433

  5. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Cystic Fibrosis 2020 cited by 151

  6. Implicating Exudate Macrophages and Ly-6Chigh Monocytes in CCR2-Dependent Lung Fibrosis following Gene-Targeted Alveolar Injury

    Authors: , , , , , , , , , , , , - The Journal of Immunology 2013 cited by 121

  7. Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2003 cited by 865

  8. Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature

    Authors: , , , , , , , , - Journal of Clinical & Translational Endocrinology 2022 cited by 23

  9. Gene-Expression Profiles in Hereditary Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2001 cited by 1,744

  10. Adaptive enrichment designs for clinical trials

    Authors: , - Biostatistics 2013 cited by 202

  11. Distinguishing right from left colon by the pattern of gene expression.

    Authors: , , , , , , , , , , , , , , , , , - 2003 cited by 284

  12. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice

    Authors: , , , , , , , , , , , , , - Journal of Clinical Investigation 2010 cited by 143

  13. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation

    Authors: , , , , , , , , , - Microbiome 2015 cited by 140

  14. Cystic Fibrosis Adult Care

    Authors: , , , , - CHEST Journal 2004 cited by 582

  15. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2001 cited by 1,085

  16. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

    Authors: , , , , , , - Journal of Clinical Investigation 1996 cited by 561

  17. Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , - CHEST Journal 2016 cited by 110

  18. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis

    Authors: , , , , , , , - PLoS ONE 2018 cited by 96

  19. Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination

    Authors: , , , , , , - mSystems 2020 cited by 34

  20. Plasminogen Activation–Induced Pericellular Fibronectin Proteolysis Promotes Fibroblast Apoptosis

    Authors: , , , , - American Journal of Respiratory Cell and Molecular Biology 2007 cited by 101

  21. PAI‐1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury

    Authors: , , , , , , , , , , , , , - The Journal of Pathology 2012 cited by 77

  22. Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome

    Authors: , , , , , , , , , , , , , , , , , , - Thorax 2020 cited by 56

  23. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

    Authors: , , , , , , , , , , , , , , , , - 2002 cited by 261

  24. Practical Bayesian Guidelines for Phase IIB Clinical Trials

    Authors: , - Biometrics 1994 cited by 243